Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
Daewon Pharmaceutical
★
Daewon Pharmaceutical Discloses 2026 Corporate Governance Report – 73% Compliance on Key Indicators, Maintains Dividend, Introduces E-Voting
06/01/2026, 01:44 PM
PERI
Daewon Pharmaceutical
★
Daewon Pharm Q1 2026 Operating Profit of 4.4B Won Turns Black… R&D Investment Continues
05/15/2026, 12:17 PM
EXCH
Daewon Pharmaceutical
★★★
2025 Consolidated Results: Operating Profit Plunges 87.8%, Net Loss Swing
05/10/2026, 07:00 PM